Timothy J. Nelson, M.D., Ph.D.
My primary project is focused on pharmacologic and cell-based assays as a means to determine the molecular etiology of the rare congenital heart defect, hypoplastic left heart syndrome. My experiments utilize patient-derived induced pluripotent stem (iPS) cells and directed cardiac differentiation as a cell-based model for cardiac development.
Secondary projects revolve around refinement of differentiation protocols and advancing the understanding of stem cell biology with regard to cardiac differentiation.
Nov. 12, 2015